Interview with James Hanlon, CEO, Clonmel Healthcare
Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal…
Address: Waterford Road, Clonmel, Co. Tipperary,Ireland
Tel: 052 617 7777
Web: http://www.clonmel-health.ie/professional/
In 2006 Clonmel Healthcare embarked on a brand redevelopment strategy following the findings of a major customer research report commissioned by the company. In early 2007 the new corporate identity was launched. The new distinctive brand mark represents Clonmel Healthcare’s core values of quality, customer service and dynamism and retains the strength of our heritage and strong link to our Irish roots.
Clonmel Healthcare currently has a large portfolio of products covering three distinct business units; Prescription medicines, Speciality medicines and the ClonMedica Consumer Division. Our prescription products cover a wide range of therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. Within the Special Products Division we have medicines for the treatment of Parkinson’s disease, Testosterone Deficiency Syndrome and the management of diabetes. The ClonMedica product range focuses on three main areas; women’s and babies health, skincare and health supplements.
Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal…
Recent announcements from Ipsen and AbbVie of multimillion Euro investments into Irish manufacturing plants underline the Celtic nation’s continuing attractiveness to pharma multinationals. While an upcoming hike in Ireland’s famously…
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch & Lomb’s EUR 90 million manufacturing investment; and a new report on…
Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key priorities of their exciting new Mercury 2021 strategy, the rationale behind their transition into…
David Adlam, Regional Manager of Ireland and South West UK, and Paul Morris, Strategic Account Manager for Life Sciences at Agility, discuss the company’s increased commitment to Ireland, their ongoing…
Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market, and more broadly in Ireland, during her extensive career at PwC.…
These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API manufacturing footprint to deal with increasing global demand for its products. “Sales from…
The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring countries struggling to interpret what ‘Brexit’ means for them. Ireland, as the UK’s…
Philip Hendrick, the Managing Director of Air Liquide Healthcare Ireland, a provider of home-based respiratory solutions, discusses the changes that the Irish healthcare system is going through, and how they…
Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help the pharmaceutical industry increase efficiency and save costs through their agile,…
Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly in North America, across both their Sharp and Ashfield business units. He also expands on…
Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve years, their comprehensive pain portfolio, the innovation they are bringing as pain specialists to…
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as proponents would say. Ireland has always faced a number of intrinsic hurdles…
See our Cookie Privacy Policy Here